Dietary fat, insulin sensitivity and the metabolic syndrome.
Level 5 - mechanism / opinion, no new human data
Narrative review of human epidemiological and intervention studies without systematic review methodology.
PubMed 15297079 · doi:10.1016/j.clnu.2004.02.006
What was done
This narrative review synthesized epidemiological evidence and human intervention trials examining the impact of dietary fat quantity and specific fat quality (saturated, monounsaturated, polyunsaturated, and omega-3 fatty acids) on body weight, insulin resistance, blood pressure, and lipid profiles.
What was found
The abstract reports qualitative directions without specific numerical effect sizes or confidence intervals. Saturated fat worsens insulin resistance, whereas monounsaturated and polyunsaturated fats improve it. Citing the multicenter KANWU study, replacing saturated fat with monounsaturated fat improved insulin sensitivity in healthy participants, whereas moderate omega-3 supplementation had no effect on insulin sensitivity. Omega-3 fatty acids reduced blood pressure in hypertensive individuals and decreased triglycerides while increasing LDL cholesterol. Shifting from saturated to monounsaturated fat reduced diastolic blood pressure, and substituting unsaturated fats for saturated fats lowered both LDL cholesterol and plasma triglycerides in insulin-resistant subjects.
Why it matters
It emphasizes that the composition of dietary fatty acids modulates insulin sensitivity and cardiovascular risk factors independently of total caloric intake or changes in body weight.
Limits
As a narrative review, it lacks systematic search criteria, quality appraisal, and meta-analytic pooling. The abstract does not provide exact numbers, effect sizes, sample sizes, or baseline characteristics of the reviewed trials.
Cited by
- context Studies in the European Journal of Clinical Nutrition showed that a high-carbohydrate, high-saturated-fat diet produced the worst insulin resistance and insulin signaling outcomes.